ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis

FRA:LLY • US5324571083

888.5 EUR
+5.8 (+0.66%)
Last: Feb 16, 2026, 07:00 PM
Fundamental Rating

6

Taking everything into account, LLY scores 6 out of 10 in our fundamental rating. LLY was compared to 52 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY is valued quite expensive, but it does show an excellent growth. These ratings would make LLY suitable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LLY was profitable.
  • LLY had a positive operating cash flow in the past year.
  • LLY had positive earnings in each of the past 5 years.
  • LLY had a positive operating cash flow in 4 of the past 5 years.
LLY.DE Yearly Net Income VS EBIT VS OCF VS FCFLLY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B

1.2 Ratios

  • With an excellent Return On Assets value of 16.02%, LLY belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
  • LLY has a better Return On Equity (77.38%) than 96.15% of its industry peers.
  • With an excellent Return On Invested Capital value of 28.89%, LLY belongs to the best of the industry, outperforming 94.23% of the companies in the same industry.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LLY.DE Yearly ROA, ROE, ROICLLY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • LLY has a Profit Margin of 30.99%. This is amongst the best in the industry. LLY outperforms 96.15% of its industry peers.
  • LLY's Profit Margin has improved in the last couple of years.
  • LLY's Operating Margin of 44.41% is amongst the best of the industry. LLY outperforms 96.15% of its industry peers.
  • In the last couple of years the Operating Margin of LLY has grown nicely.
  • With an excellent Gross Margin value of 83.03%, LLY belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
  • LLY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
LLY.DE Yearly Profit, Operating, Gross MarginsLLY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LLY is creating value.
  • There is no outstanding debt for LLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LLY.DE Yearly Shares OutstandingLLY.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY.DE Yearly Total Debt VS Total AssetsLLY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 8.29 indicates that LLY is not in any danger for bankruptcy at the moment.
  • LLY's Altman-Z score of 8.29 is amongst the best of the industry. LLY outperforms 96.15% of its industry peers.
  • LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
  • LLY's Debt to FCF ratio of 6.60 is in line compared to the rest of the industry. LLY outperforms 44.23% of its industry peers.
  • LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
  • LLY has a worse Debt to Equity ratio (1.72) than 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.29
ROIC/WACC3.17
WACC9.11%
LLY.DE Yearly LT Debt VS Equity VS FCFLLY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.55, LLY is doing good in the industry, outperforming 61.54% of the companies in the same industry.
  • A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.24, LLY is in the better half of the industry, outperforming 71.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY.DE Yearly Current Assets VS Current LiabilitesLLY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

9

3. Growth

3.1 Past

  • LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.23%, which is quite impressive.
  • LLY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.01% yearly.
  • The Revenue has grown by 44.70% in the past year. This is a very strong growth!
  • LLY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.58% yearly.
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%

3.2 Future

  • Based on estimates for the next years, LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 20.61% on average per year.
  • LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.73% yearly.
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y20.61%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y14.73%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LLY.DE Yearly Revenue VS EstimatesLLY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
LLY.DE Yearly EPS VS EstimatesLLY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 43.53 indicates a quite expensive valuation of LLY.
  • Compared to the rest of the industry, the Price/Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 65.38% of the companies listed in the same industry.
  • LLY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.19.
  • Based on the Price/Forward Earnings ratio of 31.40, the valuation of LLY can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 67.31% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. LLY is around the same levels.
Industry RankSector Rank
PE 43.53
Fwd PE 31.4
LLY.DE Price Earnings VS Forward Price EarningsLLY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • LLY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. LLY is more expensive than 69.23% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, LLY is valued a bit more expensive than the industry average as 65.38% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 154.8
EV/EBITDA 36.14
LLY.DE Per share dataLLY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of LLY may justify a higher PE ratio.
  • A more expensive valuation may be justified as LLY's earnings are expected to grow with 23.44% in the coming years.
PEG (NY)1.13
PEG (5Y)1.74
EPS Next 2Y31.04%
EPS Next 3Y23.44%

4

5. Dividend

5.1 Amount

  • LLY has a yearly dividend return of 0.67%, which is pretty low.
  • LLY's Dividend Yield is comparable with the industry average which is at 1.89.
  • With a Dividend Yield of 0.67, LLY pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.67%

5.2 History

  • The dividend of LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
LLY.DE Yearly Dividends per shareLLY.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • 28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
  • LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
LLY.DE Yearly Income VS Free CF VS DividendLLY.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B
LLY.DE Dividend Payout.LLY.DE Dividend Payout, showing the Payout Ratio.LLY.DE Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

FRA:LLY (2/16/2026, 7:00:00 PM)

888.5

+5.8 (+0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap839.97B
Revenue(TTM)65.18B
Net Income(TTM)18.41B
Analysts80.54
Price Target994.71 (11.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.67%
Yearly Dividend4.16
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)5.78%
PT rev (3m)26.22%
EPS NQ rev (1m)-6.21%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)2.31%
EPS NY rev (3m)7.96%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)1.78%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 43.53
Fwd PE 31.4
P/S 16.77
P/FCF 154.8
P/OCF 62.03
P/B 41.88
P/tB 87.03
EV/EBITDA 36.14
EPS(TTM)20.41
EY2.3%
EPS(NY)28.3
Fwd EY3.18%
FCF(TTM)5.74
FCFY0.65%
OCF(TTM)14.32
OCFY1.61%
SpS52.99
BVpS21.22
TBVpS10.21
PEG (NY)1.13
PEG (5Y)1.74
Graham Number98.71
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.89%
ROICexc 33.3%
ROICexgc 41.12%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.29
F-Score7
WACC9.11%
ROIC/WACC3.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y20.61%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y14.73%
EBIT growth 1Y82.81%
EBIT growth 3Y53.07%
EBIT growth 5Y34.09%
EBIT Next Year43.42%
EBIT Next 3Y24.82%
EBIT Next 5Y21.25%
FCF growth 1Y382.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.27%
OCF growth 3YN/A
OCF growth 5YN/A

ELI LILLY & CO / LLY.DE FAQ

Can you provide the ChartMill fundamental rating for ELI LILLY & CO?

ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.


What is the valuation status of ELI LILLY & CO (LLY.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY.DE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for LLY stock?

The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY.DE) is 43.53 and the Price/Book (PB) ratio is 41.88.


What is the earnings growth outlook for ELI LILLY & CO?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 38.64% in the next year.